Neuropsychiatric Systemic Lupus Erythematosus

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Neuropsychiatric Systemic Lupus Erythematosus trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05934149

Lupus Landmark Study: A Prospective Registry and Biorepository

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of…

United States3,500 participantsStarted 2023-06-28

All recent trials (7 shown)

CompletedPhase 2

NCT07281105

EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study

Neuropsychiatric systemic lupus erythematosus with cognitive impairment (NPSLE-CI) is a serious, disabling, and potentially life-threatening manifestation of SL…

United States131 participantsStarted 2018-08-23

Treatment: Placebo, EG-501

WithdrawnNot Applicable

NCT00858884

Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus

The purpose of this study is to determine whether Libman-Sacks endocarditis (inflammation of the heart valves) is the cause of neuropsychiatric manifestations (…

United States0Started 2006-08

Treatment: Clinical and laboratory evaluations, transesophageal echocardiography, carotid duplex, transcranial duplex, and magnetic resonance of the brain

Neuropsychiatric Systemic Lupus Erythematosus

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Lupus Landmark Study: A Prospective Registry and Biorepository

All recent trials (7 shown)

EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study

Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Lupus Landmark Study: A Prospective Registry and Biorepository

All recent trials (7 shown)

EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study

Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus

Neuron-specific Humoral and Cellular Immune Correlates of Structural and Functional Brain Connectomics in Neuropsychiatr…

Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus

Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus

Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus